Inari Medical shares are trading lower after the company reported Q2 financial results and issued FY24 revenue guidance below estimates. Also, Truist Securities and Baird lowered their respective price targets on the stock.
Portfolio Pulse from Benzinga Newsdesk
Inari Medical shares are trading lower after the company reported Q2 financial results and issued FY24 revenue guidance below estimates. Truist Securities and Baird also lowered their price targets on the stock.
July 31, 2024 | 4:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Inari Medical shares are trading lower due to disappointing Q2 financial results and FY24 revenue guidance below estimates. Additionally, Truist Securities and Baird have lowered their price targets on the stock.
The company's Q2 financial results and FY24 revenue guidance were below market expectations, leading to a negative market reaction. The lowered price targets by Truist Securities and Baird further contribute to the bearish sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100